claim
The first-generation senolytic drug ABT263 clears senescent astrocytes and microglia, modulates tau aggregation, and inhibits tau-associated cognitive decline.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (1)
- microglia concept